Triple negative breast cancer (TNBC) which is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (Her-2) accounts for 10–20% of all breast cancer. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.